+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

2019 Post-Traumatic Stress Disorder (PTSD) Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

  • ID: 4768177
  • Report
  • 276 pages
  • VPA Research
1 of 4

FEATURED COMPANIES

  • Allergan Plc
  • AstraZeneca Plc
  • GlaxoSmithKline Plc
  • Johnson & Johnson
  • Otsuka Holdings Co Ltd
  • Pfizer Inc
  • MORE
The global clinical trial report- “2019 Post-Traumatic Stress Disorder (PTSD) Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Post-Traumatic Stress Disorder (PTSD). It presents in-depth analysis of Post-Traumatic Stress Disorder (PTSD) clinical trials across markets and companies. The research work is for providing complete understanding into trends in Post-Traumatic Stress Disorder (PTSD).

The report covers a key snapshot of trial trends, enrollment trends, success trends, locations and other trends.

It also segments the Post-Traumatic Stress Disorder (PTSD) clinical trials by:
  • Current Trial Status
  • Type of the trial
  • Sponsor Type
  • Enrollment Trends
  • Region
  • Countries
  • Trial Phase
The report also identifies the potential drug candidates under development for treatment of Post-Traumatic Stress Disorder (PTSD)

The research work is prepared through extensive and continuous research on Post-Traumatic Stress Disorder (PTSD) trials from over 1500 sources including company websites, conferences and presentations, scientific journals, country wise and global clinical trial registries, news, health and science departments among others.

Report Scope and Coverage:
  • All major trials from 2010 to 2019 and planned trials are included in the report scope.
  • Drug candidates currently being researched for administering Post-Traumatic Stress Disorder (PTSD) patients are identified
  • The report includes panorama of Post-Traumatic Stress Disorder (PTSD) clinical trials across the globe
  • Trial Phase, Current Status, Sponsor Type, Location, trial type and Enrollment details are provided
  • Companies and universities focusing on Post-Traumatic Stress Disorder (PTSD) clinical trials are analyzed along with their trial participation (trial title, trial phase and current status)
  • Average Enrollment number, insights into enrollment trends, company wise enrollment are included
  • Both interventional and observational studies are analyzed
  • News and latest developments for the past one year are presented in the report
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Allergan Plc
  • AstraZeneca Plc
  • GlaxoSmithKline Plc
  • Johnson & Johnson
  • Otsuka Holdings Co Ltd
  • Pfizer Inc
  • MORE
1.1 List of Figures
1.2 List of Tables

2. Executive Summary
2.1 Post-Traumatic Stress Disorder (PTSD) Clinical Trials Overview, 2019
2.2 Premium Insights into Clinical Trials
2.2.1 Post-Traumatic Stress Disorder (PTSD) Clinical Trials by Region
2.2.2 Average Enrollment of Post-Traumatic Stress Disorder (PTSD) Clinical Trials
2.2.3 Companies participating in Trials
2.2.4 Drugs under Study for Post-Traumatic Stress Disorder (PTSD) Treatment, 2019

3. Region wise Post-Traumatic Stress Disorder (PTSD) Clinical Trials
3.1 Asia Pacific Post-Traumatic Stress Disorder (PTSD) Clinical Trials by Country
3.2 Europe Post-Traumatic Stress Disorder (PTSD) Clinical Trials by Country
3.3 North America Post-Traumatic Stress Disorder (PTSD) Clinical Trials by Country
3.4 Middle East and Africa Post-Traumatic Stress Disorder (PTSD) Clinical Trials by Country
3.5 South and Central America Post-Traumatic Stress Disorder (PTSD) Clinical Trials by Country

4. Post-Traumatic Stress Disorder (PTSD) Clinical Trial Trends
4.1 Start Year wise Post-Traumatic Stress Disorder (PTSD) Clinical Trials
4.2 Phase wise Post-Traumatic Stress Disorder (PTSD) Clinical Trials
4.3 Trial Status wise Post-Traumatic Stress Disorder (PTSD) Clinical Trials
4.4 Trial Type wise Post-Traumatic Stress Disorder (PTSD) Clinical Trials

5. Post-Traumatic Stress Disorder (PTSD) Average Enrollment Trends
5.1 Average Enrollment in Post-Traumatic Stress Disorder (PTSD) Trials by Year
5.2 Average Enrollment in Post-Traumatic Stress Disorder (PTSD) Trials by Phase
5.3 Average Enrollment in Post-Traumatic Stress Disorder (PTSD) Trials by Status
5.4 Average Enrollment in Post-Traumatic Stress Disorder (PTSD) Trials by Type of Trial

6. Companies Participating in Post-Traumatic Stress Disorder (PTSD) Clinical Trials
6.1 Post-Traumatic Stress Disorder (PTSD) Trials by Sponsor Type
6.2 Post-Traumatic Stress Disorder (PTSD) Average Enrollment by Sponsor Type
6.3 Subjects Recruited by Leading Sponsors

7. Trial Snapshots- Phase, Type, Title, Location, Start Year, Completion Year, Recruitment Status, Enrollment, Participating Countries, Trial Locations, Company, Drugs and Other Details
7.1 Post-Traumatic Stress Disorder (PTSD) Trials- Phase 1
7.2 Post-Traumatic Stress Disorder (PTSD) Trials- Phase 2
7.3 Post-Traumatic Stress Disorder (PTSD) Trials- Phase 3
7.4 Post-Traumatic Stress Disorder (PTSD) Trials- Phase 4

8. Appendix
8.1 Report Guidance
8.2 Research Methodology
8.3 Abbreviations
8.4 Definitions
8.5 Sources
8.6 Publisher Expertise

List of Figures
Figure 1: Post-Traumatic Stress Disorder (PTSD) Clinical Trials by Region, 2019
Figure 2: Country wise Clinical Trials, 2019
Figure 3: Country wise Average Enrolment, 2019
Figure 4: Asia Pacific - Country wise Post-Traumatic Stress Disorder (PTSD) Clinical Trials and Enrolment
Figure 5: Europe - Country wise Post-Traumatic Stress Disorder (PTSD) Clinical Trials and Enrolment
Figure 6: Middle East Africa - Country wise Post-Traumatic Stress Disorder (PTSD) Clinical Trials and Enrolment
Figure 7: North America - Country wise Post-Traumatic Stress Disorder (PTSD) Clinical Trials and Enrolment
Figure 8: South and Central America - Country wise Post-Traumatic Stress Disorder (PTSD) Clinical Trials and Enrolment
Figure 9: Post-Traumatic Stress Disorder (PTSD) Clinical Trials by Phase
Figure 10: Post-Traumatic Stress Disorder (PTSD) Clinical Trials by Trial Status
Figure 11: Post-Traumatic Stress Disorder (PTSD) Clinical Trials by Type
Figure 12: Post-Traumatic Stress Disorder (PTSD) Clinical Trials by Sponsor Type
Figure 13: Post-Traumatic Stress Disorder (PTSD) Clinical Trials by Leading Sponsors
Figure 14: Post-Traumatic Stress Disorder (PTSD) Average Enrollment by Phase
Figure 15: Post-Traumatic Stress Disorder (PTSD) Average Enrollment by Trial Status
Figure 16: Post-Traumatic Stress Disorder (PTSD) Average Enrollment by Type
Figure 17: Post-Traumatic Stress Disorder (PTSD)- Average Enrolment by Type of Sponsors
Figure 18: Post-Traumatic Stress Disorder (PTSD)- Enrolment by Leading Sponsors
Figure 19: Research Methodology

List of Tables
Table 1: Post-Traumatic Stress Disorder (PTSD) Clinical Trials Snapshot- 2019
Table 2: Trials by Region, 2019
Table 3: Country wise Clinical Trials and Average Enrolment by Country, 2019
Table 4: Asia Pacific - Country wise Post-Traumatic Stress Disorder (PTSD) Clinical Trials and Enrolment
Table 5: Europe - Country wise Post-Traumatic Stress Disorder (PTSD) Clinical Trials and Enrolment
Table 6: Middle East Africa - Country wise Post-Traumatic Stress Disorder (PTSD) Clinical Trials and Enrolment
Table 7: North America - Country wise Post-Traumatic Stress Disorder (PTSD) Clinical Trials and Enrolment
Table 8: South and Central America - Country wise Post-Traumatic Stress Disorder (PTSD) Clinical Trials and Enrolment
Table 9: Clinical Trials by Phase
Table 10: Clinical Trials by Trial Status
Table 11: Clinical Trials by Type
Table 12: Clinical Trials by Sponsor Type
Table 13: Clinical Trials by Leading Sponsors
Table 14: Post-Traumatic Stress Disorder (PTSD) Average Enrollment by Phase
Table 15: Post-Traumatic Stress Disorder (PTSD) Average Enrollment by Trial Status
Table 16: Post-Traumatic Stress Disorder (PTSD) Average Enrollment by Type
Table 17: Post-Traumatic Stress Disorder (PTSD)- Average Enrolment by Type of Sponsors
Table 18: Post-Traumatic Stress Disorder (PTSD)- Enrolment by Leading Sponsors
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Allergan Plc
  • AstraZeneca Plc
  • GlaxoSmithKline Plc
  • Johnson & Johnson
  • Otsuka Holdings Co Ltd
  • Pfizer Inc
  • Premier Research Group Ltd
  • Synthon Holdings BV
  • Tonix Pharmaceuticals Holding Corp
  • Tuscaloosa Research & Education Advancement
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Order Online - visit: https://www.researchandmarkets.com/reports/4768177
Adroll
adroll